Login / Signup

The impact of zinc supplementation on galectin-3 and metabolic markers in diabetic patients on hemodialysis: A randomized, double-blind, placebo-controlled trial.

Razieh HosseiniMansour KarajibaniFarzaneh MontazerifarElham ShahrakiKhatereh BabakhaniAli Mohammad MokhtariAmirhossein Sahebkar
Published in: Journal of diabetes and metabolic disorders (2022)
IRCT20191217045765N1, date of registration: 2020-02-09.
Keyphrases
  • double blind
  • placebo controlled
  • clinical trial
  • end stage renal disease
  • peritoneal dialysis
  • chronic kidney disease
  • oxide nanoparticles
  • phase iii
  • study protocol
  • phase ii